Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

Moo TA, Sanford R, Dang C, Morrow M. Overview of breast cancer therapy. PET Clin. 2018;13(3):339–54. https://doi.org/10.1016/j.cpet.2018.02.006.

Article  PubMed  PubMed Central  Google Scholar 

Cruceriu D, Baldasici O, Balacescu O, Berindan-Neagoe I. The dual role of tumor necrosis factor-alpha (TNF-α) in breast cancer: molecular insights and therapeutic approaches. Cell Oncol. 2020;43(1):1–18. https://doi.org/10.1007/s13402-019-00489-1.

Article  CAS  Google Scholar 

Chen Y, Zhang B, Bao L, Jin L, Yang M, Peng Y, et al. ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis. J Clin Invest. 2018;128(5):1937–55. https://doi.org/10.1172/jci95089.

Article  PubMed  PubMed Central  Google Scholar 

Hashemi M, Arani HZ, Orouei S, Fallah S, Ghorbani A, Khaledabadi M, et al. EMT mechanism in breast cancer metastasis and drug resistance: revisiting molecular interactions and biological functions. Biomed Pharmacother. 2022;155: 113774. https://doi.org/10.1016/j.biopha.2022.113774.

Article  CAS  PubMed  Google Scholar 

Blandin AF, Renner G, Lehmann M, Lelong-Rebel I, Martin S, Dontenwill M. β1 integrins as therapeutic targets to disrupt hallmarks of cancer. Front Pharmacol. 2015;6:279. https://doi.org/10.3389/fphar.2015.00279.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sahana J, Cortés-Sánchez JL, Sandt V, Melnik D, Corydon TJ, Schulz H, et al. Long-term simulation of microgravity induces changes in gene expression in breast cancer cells. Int J Mol Sci. 2023. https://doi.org/10.3390/ijms24021181.

Article  PubMed  PubMed Central  Google Scholar 

Takada Y, Ye X, Simon S. The integrins. Genome Biol. 2007;8(5):215. https://doi.org/10.1186/gb-2007-8-5-215.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yousefi H, Vatanmakanian M, Mahdiannasser M, Mashouri L, Alahari NV, Monjezi MR, et al. Understanding the role of integrins in breast cancer invasion, metastasis, angiogenesis, and drug resistance. Oncogene. 2021;40(6):1043–63. https://doi.org/10.1038/s41388-020-01588-2.

Article  CAS  PubMed  Google Scholar 

Mao L, Wang L, Xu J, Zou J. The role of integrin family in bone metabolism and tumor bone metastasis. Cell Death Discov. 2023;9(1):119. https://doi.org/10.1038/s41420-023-01417-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campbell ID, Humphries MJ. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol. 2011. https://doi.org/10.1101/cshperspect.a004994.

Article  PubMed  PubMed Central  Google Scholar 

Li J, Peng L, Chen Q, Ye Z, Zhao T, Hou S, et al. Integrin β1 in pancreatic cancer: expressions, functions, and clinical implications. Cancers. 2022. https://doi.org/10.3390/cancers14143377.

Article  PubMed  PubMed Central  Google Scholar 

Guarin JR, Fatherree JP, Oudin MJ. Chemotherapy treatment induces pro-invasive changes in liver ECM composition. Matrix Biol. 2022;112:20–38. https://doi.org/10.1016/j.matbio.2022.08.002.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sabherwal Y, Rothman VL, Dimitrov S, L’Heureux DZ, Marcinkiewicz C, Sharma M, et al. Integrin alpha2beta1 mediates the anti-angiogenic and anti-tumor activities of angiocidin, a novel tumor-associated protein. Exp Cell Res. 2006;312(13):2443–53. https://doi.org/10.1016/j.yexcr.2006.04.009.

Article  CAS  PubMed  Google Scholar 

Moritz MNO, Casali BC, Stotzer US, Karina Dos Santos P, Selistre-de-Araujo HS. Alternagin-C, an alpha2beta1 integrin ligand, attenuates collagen-based adhesion, stimulating the metastasis suppressor 1 expression in triple-negative breast tumor cells. Toxicon. 2022;210:1–10. https://doi.org/10.1016/j.toxicon.2022.02.001.

Article  CAS  PubMed  Google Scholar 

Moritz MNO, Merkel AR, Feldman EG, Selistre-de-Araujo HS, Rhoades Sterling JA. Biphasic α2β1 integrin expression in breast cancer metastasis to bone. Int J Mol Sci. 2021. https://doi.org/10.3390/ijms22136906.

Article  PubMed  PubMed Central  Google Scholar 

Zhou B, Li M, Xu X, Yang L, Ye M, Chen Y, et al. Integrin α(2)β(1) targeting DGEA-modified liposomal doxorubicin enhances antitumor efficacy against breast cancer. Mol Pharm. 2021;18(7):2634–46. https://doi.org/10.1021/acs.molpharmaceut.1c00132.

Article  CAS  PubMed  Google Scholar 

Zuo XX, Yang Y, Zhang Y, Zhang ZG, Wang XF, Shi YG. Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway. Cell Commun Signal. 2019;17(1):142. https://doi.org/10.1186/s12964-019-0464-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moritz MNO, Eustáquio LMS, Micocci KC, Nunes ACC, Dos Santos PK, de Castro Vieira T, et al. Alternagin-C binding to α(2)β(1) integrin controls matrix metalloprotease-9 and matrix metalloprotease-2 in breast tumor cells and endothelial cells. J Venom Anim Toxins Incl Trop Dis. 2018;24:13. https://doi.org/10.1186/s40409-018-0150-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morozevich GE, Kozlova NI, Susova OY, Karalkin PA, Berman AE. Implication of α2β1 integrin in anoikis of MCF-7 human breast carcinoma cells. Biochemistry. 2015;80(1):97–103. https://doi.org/10.1134/s0006297915010113.

Article  CAS  PubMed  Google Scholar 

Haidari M, Zhang W, Caivano A, Chen Z, Ganjehei L, Mortazavi A, et al. Integrin α2β1 mediates tyrosine phosphorylation of vascular endothelial cadherin induced by invasive breast cancer cells. J Biol Chem. 2012;287(39):32981–92. https://doi.org/10.1074/jbc.M112.395905.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Czeczuga-Semeniuk E, Lemancewicz D, Wołczyński S. Estradiol and tamoxifen differently affects the inhibitory effects of vitamin A and their metabolites on the proliferation and expression of alpha2beta1 integrins in MCF-7 breast cancer cells. Adv Med Sci. 2009;54(1):91–8. https://doi.org/10.2478/v10039-009-0021-8.

Article  CAS  PubMed  Google Scholar 

Rosfjord EC, Maemura M, Johnson MD, Torri JA, Akiyama SK, Woods VL Jr, et al. Activation of protein kinase C by phorbol esters modulates alpha2beta1 integrin on MCF-7 breast cancer cells. Exp Cell Res. 1999;248(1):260–71. https://doi.org/10.1006/excr.1998.4390.

Article  CAS  PubMed  Google Scholar 

Miskin RP, Warren JSA, Ndoye A, Wu L, Lamar JM, DiPersio CM. Integrin α3β1 promotes invasive and metastatic properties of breast cancer cells through induction of the Brn-2 transcription factor. Cancers. 2021. https://doi.org/10.3390/cancers13030480.

Article  PubMed  PubMed Central  Google Scholar 

Mitchell K, Svenson KB, Longmate WM, Gkirtzimanaki K, Sadej R, Wang X, et al. Suppression of integrin alpha3beta1 in breast cancer cells reduces cyclooxygenase-2 gene expression and inhibits tumorigenesis, invasion, and cross-talk to endothelial cells. Cancer Res. 2010;70(15):6359–67. https://doi.org/10.1158/0008-5472.Can-09-4283.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu X, Mu E, Wei Y, Riethdorf S, Yang Q, Yuan M, et al. VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. Cancer Cell. 2011;20(6):701–14. https://doi.org/10.1016/j.ccr.2011.11.002.

Article